The Short Report

TELO
Telo Therapeutics

1 report on Telo Therapeutics (TELO) by White Diamond Research, summarized: the thesis, evidence and key numbers. Latest: Dec 13, 2024.

No spam. Unsubscribe anytime.

All Reports TELO × / Market Intelligence

TELO

1 of 1 reports
TELO —
—
TELO Telo Therapeutics

Telomir Pharmaceuticals Is A Biotech Pump And Dump Scheme Remaining In the Preclinical Stage

Telomir Pharmaceuticals (TELO) exposed: Biotech pump and dump scheme with missing preclinical data, questionable founder history, extreme overvaluation, and potential stock collapse under $1 in 2025

White Diamond Research
Dec 13, 2024